Investment for health and wellbeing

Join our Q1 2024 results webcast on 25 April 2024 at 10 a.m. EEST

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q1 2024

Sales growth and improved profitability

Download Q1 report Download Q1 presentation Join the webcast at 10 a.m. EEST

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Annual General Meeting 2023

Oriola's AGM was held on 19 March 2024. Thank you to all shareholders who participated at the AGM.

Resolutions of the AGM Watch recording of CEO's review Read more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

25.04.2024 | Stock exchange releases

Oriola Corporation’s Interim Report January-March 2024
19.03.2024 | Stock exchange releases

Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors
15.03.2024 | Stock exchange releases

Oriola Corporation’s disposal of own shares based on the share-based incentive plan
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts